Measurement of the penetration of 56 cosmetic relevant chemicals into and through human skin using a standardized protocol.


Journal

Journal of applied toxicology : JAT
ISSN: 1099-1263
Titre abrégé: J Appl Toxicol
Pays: England
ID NLM: 8109495

Informations de publication

Date de publication:
03 2020
Historique:
received: 14 06 2019
revised: 30 09 2019
accepted: 30 09 2019
pubmed: 24 12 2019
medline: 13 7 2021
entrez: 24 12 2019
Statut: ppublish

Résumé

OECD test guideline 428 compliant protocol using human skin was used to test the penetration of 56 cosmetic-relevant chemicals. The penetration of finite doses (10 μL/cm

Identifiants

pubmed: 31867769
doi: 10.1002/jat.3913
pmc: PMC7027575
doi:

Substances chimiques

Cosmetics 0
Solvents 0
Ethanol 3K9958V90M

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-415

Informations de copyright

© 2019 The Authors. Journal of Applied Toxicology published by John Wiley & Sons Ltd.

Références

J Pharm Sci. 2006 Feb;95(2):268-80
pubmed: 16381026
Skin Pharmacol Physiol. 2011;24(4):224-30
pubmed: 21455015
J Control Release. 2013 Jan 28;165(2):119-28
pubmed: 23099116
Adv Drug Deliv Rev. 2004 Mar 27;56(5):603-18
pubmed: 15019749
SAR QSAR Environ Res. 2007 Jan-Mar;18(1-2):31-44
pubmed: 17365957
J Invest Dermatol. 1970 May;54(5):399-404
pubmed: 4245370
Br J Dermatol. 1986 Jul;115(1):1-11
pubmed: 3730275
Pharm Res. 1992 May;9(5):663-9
pubmed: 1608900
J Appl Toxicol. 2019 Feb;39(2):385-397
pubmed: 30345528
Toxicol Appl Pharmacol. 1975 May;32(2):394-8
pubmed: 1154403
J Invest Dermatol. 1972 Mar;58(3):114-23
pubmed: 4622425
Adv Drug Deliv Rev. 2013 Feb;65(2):221-36
pubmed: 22285584
J Pharm Sci. 2012 Jul;101(7):2584-95
pubmed: 22517028
Br J Dermatol. 2009 Jan;160(1):80-91
pubmed: 18811683
Pharm Res. 2016 Jul;33(7):1602-14
pubmed: 26956458
Toxicol In Vitro. 2016 Aug;34:153-160
pubmed: 27039122
Skin Pharmacol Physiol. 2017;30(5):234-245
pubmed: 28746940
J Pharm Sci. 2005 Mar;94(3):632-8
pubmed: 15666298
J Clin Endocrinol Metab. 2000 Dec;85(12):4500-10
pubmed: 11134099
Regul Toxicol Pharmacol. 2004 Jun;39(3):271-81
pubmed: 15135208
Br J Clin Pharmacol. 2011 Nov;72(5):768-74
pubmed: 21599723
J Toxicol Environ Health A. 2010;73(4):284-300
pubmed: 20077298
Arzneimittelforschung. 1995 Oct;45(10):1117-21
pubmed: 8595072
J Invest Dermatol. 1969 Jan;52(1):89-94
pubmed: 5761932
J Invest Dermatol. 1976 Oct;67(4):518-20
pubmed: 823268
Pharm Res. 1992 Sep;9(9):1164-7
pubmed: 1409398
Skin Pharmacol Physiol. 2019;32(3):117-124
pubmed: 30889606
Regul Toxicol Pharmacol. 2016 Apr;76:174-86
pubmed: 26825378
Food Chem Toxicol. 2007 Dec;45(12):2533-62
pubmed: 17664037
Clin Pharmacol Drug Dev. 2018 Sep;7(7):684-691
pubmed: 29323795
J Appl Toxicol. 2020 Mar;40(3):403-415
pubmed: 31867769
Curr Probl Dermatol. 1978;7:58-68
pubmed: 752458
J Invest Dermatol. 1988 Jul;91(1):29-33
pubmed: 3385214
J Appl Toxicol. 2017 Jul;37(7):806-816
pubmed: 28139006

Auteurs

Nicola J Hewitt (NJ)

ADME Task Force, Cosmetics Europe, Brussels, Belgium.

Sébastien Grégoire (S)

L'Oreal Research and Innovation, Aulnay-Sous-Bois, France.

Richard Cubberley (R)

Unilever, Bedfordshire, UK.

Hélène Duplan (H)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Joan Eilstein (J)

L'Oreal Research and Innovation, Aulnay-Sous-Bois, France.

Corie Ellison (C)

The Procter and Gamble Company, Cincinnati, Ohio.

Cathy Lester (C)

The Procter and Gamble Company, Cincinnati, Ohio.

Eric Fabian (E)

BASF, Ludwigshafen, Germany.

Julien Fernandez (J)

Eurofins I ADME Bioanalysis, Vergeze, France.

Camille Géniès (C)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Carine Jacques-Jamin (C)

Pierre Fabre Dermo-Cosmétique, Toulouse, France.

Martina Klaric (M)

ADME Task Force, Cosmetics Europe, Brussels, Belgium.

Helga Rothe (H)

Procter and Gamble (currently Coty), Darmstadt, Germany.

Ian Sorrell (I)

Unilever, Bedfordshire, UK.

Daniela Lange (D)

Beiersdorf AG, Hamburg, Germany.

Andreas Schepky (A)

Beiersdorf AG, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH